BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12878165)

  • 1. Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript.
    Blume SW; Miller DM; Guarcello V; Shrestha K; Meng Z; Snyder RC; Grizzle WE; Ruppert JM; Gartland GL; Stockard CR; Jones DE; Emanuel PD
    Exp Cell Res; 2003 Aug; 288(1):131-42. PubMed ID: 12878165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites.
    Nanbru C; Prats AC; Droogmans L; Defrance P; Huez G; Kruys V
    Oncogene; 2001 Jul; 20(31):4270-80. PubMed ID: 11464293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight control of platelet-derived growth factor B/c-sis expression by interplay between the 5'-untranslated region sequence and the major upstream promoter.
    Han B; Dong Z; Zhang JT
    J Biol Chem; 2003 Nov; 278(47):46983-93. PubMed ID: 12960151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5'UTR.
    Carter PS; Jarquin-Pardo M; De Benedetti A
    Oncogene; 1999 Jul; 18(30):4326-35. PubMed ID: 10439040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.
    Ma T; Mahajan PB; Thompson EA
    Mol Endocrinol; 1992 Jun; 6(6):960-8. PubMed ID: 1495494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.
    Park DS; Razani B; Lasorella A; Schreiber-Agus N; Pestell RG; Iavarone A; Lisanti MP
    Biochemistry; 2001 Mar; 40(11):3354-62. PubMed ID: 11258956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of new human c-myc mRNA species produced by alternative splicing.
    Bodescot M; Brison O
    Gene; 1996 Sep; 174(1):115-20. PubMed ID: 8863737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two haplotypes of 5' untranslated region in L-myc gene with different internal ribosome entry site activity.
    Kumimoto H; Yamane Y; Ishizaki K
    Int J Oncol; 2005 Jan; 26(1):287-93. PubMed ID: 15586251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.
    Choi H; Jackson NL; Shaw DR; Emanuel PD; Liu YL; Tousson A; Meng Z; Blume SW
    J Cell Biochem; 2008 Nov; 105(4):1092-108. PubMed ID: 18816594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological Expression and Accumulation of the Products of Two Upstream Open Reading Frames mrtl and MycHex1 Along With p64 and p67 Myc From the Human c-myc Locus.
    Ji MH; Kim SK; Kim CY; Phi JH; Jun HJ; Blume SW; Choi HS
    J Cell Biochem; 2016 Jun; 117(6):1407-18. PubMed ID: 26552949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
    Ogami K; Hosoda N; Funakoshi Y; Hoshino S
    Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory domains within the P0 promoter of human c-myc.
    Lang JC; Wilkie NM; Clark AM; Chudleigh A; Talbot S; Whitelaw B; Frame MC
    Oncogene; 1991 Nov; 6(11):2067-75. PubMed ID: 1945411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5'-untranslated RNA of the human dhfr minor transcript alters transcription pre-initiation complex assembly at the major (core) promoter.
    Blume SW; Meng Z; Shrestha K; Snyder RC; Emanuel PD
    J Cell Biochem; 2003 Jan; 88(1):165-80. PubMed ID: 12461786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress.
    Subkhankulova T; Mitchell SA; Willis AE
    Biochem J; 2001 Oct; 359(Pt 1):183-92. PubMed ID: 11563982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells.
    Peng X; Mehta RG; Tonetti DA; Christov K
    Oncogene; 2005 Feb; 24(7):1296-301. PubMed ID: 15558014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME; Lemieux R; Jung D
    J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the 5' and 3' untranslated regions in murine mdm2 mRNAs.
    Mendrysa SM; McElwee MK; Perry ME
    Gene; 2001 Feb; 264(1):139-46. PubMed ID: 11245988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.